NEW YORK (TheStreet) -- CHANGE IN RATINGS
rated new Equal-weight at Morgan Stanley. $23 price target. Stock is already pricing in expected earnings growth.
American Axle & Manufacturing
downgraded at Credit Suisse to Neutral from Outperform on valuation. Maintain $10 price target. 2010 and 2011 EPS estimates set at 82 cents and $1.24, respectively.
rated new Hold at Deutsch. $57.50 price target. Company is a leader, but already trades at the high end of the industry valuation range.
downgraded at JP Morgan. Rating lowered to Underweight from Neutral. Maintains $31 price target. Raises 2010 EPS estimates to $1.77 from $1.70.
upgraded at Credit Suisse to Outperform from Neutral as PayPal is growth driver. Price target jumped to $32 from $25. 2010 and 2011 EPS estimates lifted to $1.69 and $1.97, respectively.
( GENZ) downgraded at Citigroup from Buy to Hold. Estimates also lowered, as forward spreads have collapsed in recent months. $42 price target.
( GENZ) downgraded at JP Morgan. Rating lowered to Underweight from Neutral. Price target lowered to $45 from $55. 2010 EPS estimates lowered to $2.00 from $2.85.
( JCG) was initiated with an Outperform rating at Robert Baird. $55 price target. Company has strong growth prospects and should continue to execute on its strategy.
upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $36 from $27. 2010 EPS estimates raised to $1.02 from $0.91.
( MIR) downgraded at Citigroup from Hold to Sell. $10 price target. Company will be hurt by lower dark spreads.
downgraded at Citigroup from Buy to Hold. $25 price target. Valuation call, as the company will be hurt by lower commodity prices.
downgraded at Citigroup from Hold to Sell. $27 price target. Earnings will be hurt by falling forward commodity prices.
downgraded at Citigroup from Buy to Hold, $30 price target. Spreads are falling and the risk to the company's upcoming rate case in Pennsylvania.
( RAH) downgraded at UBS from Buy to Neutral. Estimates also lowered, because of a struggling private-label environment. $72 price target.
Research in Motion
( RIMM) rated new Market Perform at Rodman. RIMM was initiated with a Market Perform rating. Unit shipments should exceed the upper end of guidance, driven by aggressive pricing.
downgraded at Citigroup from Hold to Sell. $3.90 price target. Company will be hurt by lower dark spreads.
downgraded at Baird from Outperform to Neutral. $27 price target. Stock appears to already be pricing in comp sales growth.
Sunstone Hotel Investors
upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $13 from $9. Raises 2010 EPS estimates to $0.30 from $0.19.
STOCK COMMENTS / EPS CHANGES
estimates, target boosted at BMO. Shares of AAPL now seen reaching $265. Estimates also raised, because of higher Mac and iPad sales. Outperform rating.
( AYE) estimates lowered at Citigroup. AYE estimates were cut through 2012. Company is seeing lower dark spreads. Hold rating and $23 price target.
( BVF) target raised at UBS. BVF target was increased to $20. Company's transition appears to be in the early stages. Buy rating.
estimates cut, target raised at UBS. Shares of CMC now seen reaching $17. On the other hand, estimates were lowered, because the company is struggling to pass along higher steel prices. Neutral rating.
target increased at Goldman. Shares of COP now seen reaching $57. Expect the restructuring plan to improve company returns. Neutral rating.
numbers increased at Citigroup. Shares of D now seen reaching $33. Estimates also raised, because of expected share buybacks. Sell rating.
Dr. Pepper Snapple
numbers raised at Citigroup. DPS estimates were increased through 2011. Company is seeing strong market share trends. Buy rating and new $42 price target.
numbers upped at Goldman. Shares of DRI now seen reaching $48. Estimates also boosted, because of higher sales expectations. Neutral rating.
( GENZ) estimates lowered at UBS. GENZ estimates were reduced through 2011. Company will likely face shipping delays with Cerezyme and Fabrazyme. $68 price target.
target boosted at Morgan Stanley to $79. Company should soon begin to trade on fiscal 2011 estimates. Overweight rating.
estimates lowered at Goldman through 2012. Company is spending more on its brands and is also facing a higher share count. Neutral rating and $77 price target.
target boosted at Citigroup to $47. See higher near-term same-store sales for the company. Buy rating.
estimates, target raised at Goldman. LEN estimates were increased through 2011. Company is realizing higher margins. Neutral rating and new $20 price target.
target raised at Kaufman to $76. Expect the company to post strong first quarter sales. Hold rating.
estimates cut, target raised at Goldman. Shares of RHT now seen reaching $30. On the other hand, estimates were reduced, because of currency trends and a higher tax rate. Neutral rating.
estimates upped at Morgan Stanley through 2012. Meetings with management suggest that a slow recovery is underway. Equal-weight rating.
target cut, estimates changed at Credit Suisse. UNS price target lowered to $32 from $35 as long-term outlook has mixed drivers. 2010 EPS estimates raised to $2.91, 2011 lowered to $2.75. Maintain Neutral rating.
This article was written by a staff member of TheStreet.com.